The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Incyte (I)
Consulting or Advisory Role - Incyte (I)
Research Funding - GlaxoSmithKline; Millennium; Novartis; Others; Sanofi
Expert Testimony - Abbvie
Clinical features and overall survival (OS) in patients (pts) with post-docetaxel (DTX) metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) therapy in the community setting.
 
William K. Oh
Honoraria - Amgen; Astellas Pharma; Bayer; Bellicum Pharmaceuticals; Dendreon; Janssen Biotech; Pfizer; Sanofi
 
Raymond Miao
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Mei Sheng Duh
No Relationships to Disclose
 
Francis Vekeman
Stock and Other Ownership Interests - DaVita; Express Scripts; Valeant Pharmaceuticals International
Research Funding - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Lundbeck; Novartis; Sanofi
 
Jennifer Sung
Employment - Sanofi
Stock and Other Ownership Interests - Novartis; Sanofi
 
Wendy Y Cheng
Research Funding - GlaxoSmithKline; Lundbeck; Novartis; Others; Pfizer; Sanofi
 
Daniel Hennessy
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Marjolaine Gauthier-Loiselle
Research Funding - Genentech; GlaxoSmithKline; Merck; Novartis; Sanofi
 
Jonathan Fortier
Research Funding - Janssen; Millennium; Novartis; Noven; Sanofi
 
Ravinder Dhawan
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Travel, Accommodations, Expenses - Sanofi